We came across a bullish thesis on Edwards Lifesciences Corporation (EW) on Substack by Natan. In this article, we will ...

Surgeons at Auckland's Greenlane Hospital have performed eight double-valve transplants using human heart valves, a spokesman for the hospital's surgical team said today, commenting on a report that ...

New 20-year data show a survival rate of 90% with few repeat surgeries after this complex operation that can only be ...

Edwards Lifesciences (NYSE: EW) stock rises after Stifel upgrades to Buy, citing potential for TAVR growth acceleration in 2025. Read more here.

CABG plus surgical aortic valve replacement for treatment of coronary disease and aortic stenosis was associated with better 5-year outcomes vs. PCI plus transcatheter aortic valve replacement in ...

For many, an annual physical can feel like more of a hassle than a necessity. But for one Papillion man, it's that physical ...

Geneos Wealth Management Inc. decreased its stake in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 2.3% ...

These latest data reinforce years of smaller studies, but whether they should change practice is a matter of debate.

PGA winner Davis Love III is recovering after undergoing open-heart surgery Jan. 21 to replace a "leaky valve." ...

Brighton Jones LLC purchased a new position in Edwards Lifesciences Co. (NYSE:EW – Free Report) in the fourth quarter, ...

Davis Love III underwent surgery last week and is now recovering at home, with eyes on breaking a PGA Tour record.

Young patients who have undergone the Ross procedure for aortic valve disease have shown excellent long-term survival, the ...